Softek Illuminate, a provider of enterprise follow-up management and discovery software, has announced the addition of advanced capabilities to their Illuminate Discovery360 Platform that enable improved follow-up adherence of lung screening patients while unifying the follow-up management of patients with Incidental Pulmonary Nodules. These new capabilities bring to light the potential for healthcare providers to establish a comprehensive lung nodule surveillance program that can save lives and create new revenue streams.
The Workflow Conscious AI™ capabilities of the Illuminate Discovery360™ Platform can now automatically extract a Lung-RADS® score from clinical reports, identify lung screening patients, add them to the Illuminate ActKnowledge™ patient follow-up management tool, and flag incidentally found lung nodule patients to risk stratify them and facilitate efficient clinical workflows.
According to Dr. Mark Perry, MD, Radiologist, Oncologic Imaging, “Implementation of a comprehensive lung nodule surveillance program is a significant step towards integrated lung cancer patient care and better patient outcomes.”
The full suite of Illuminate applications, including the Workflow Conscious AI™ capabilities, will be available for demonstration at the upcoming 2023 American Thoracic Society International Conference (ATS), where Illuminate is set to sponsor a Guru Bar presentation on May 22 at 11:30 ET. The presentation, titled “Lung Nodule Surveillance: Why Screening Alone is Not Enough,” will discuss how artificial intelligence and incidental pulmonary nodule patient surveillance can augment lung cancer screening to improve health equity, close gaps in care, and improve resource utilization.
The combination of the skills of Softek Illuminate’s nurse navigators with the understanding of patient follow-up and management workflow and Illuminate ActKnowledge™ Workflow Conscious AI™ eliminates gaps in care, saves lives, and creates new revenue opportunities. According to Matt McLenon, CEO, “Workflow automation will be the driving force to make healthcare providers more productive. Illuminate uniquely enables problem-oriented data aggregation, which is critical for safe and efficient management of these large and complex patient cohorts.”
Softek Illuminate’s Discovery360™ platform provides end-to-end discovery, follow-up, and patient management solutions for hospitals and health systems. The Illuminate Platform enables healthcare organizations to deliver outstanding patient care while growing revenue throughout the patient journey. For more information, visit https://www.illuminate.ai/.
